Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Pharmaceutical Distribution	2.69B
Pharmaceutical Distribution Growth	-29.27%
Anti-Infective Drugs	1.88B
Anti-Infective Drugs Growth	8.87%
Cardiovascular Drugs	1.34B
Cardiovascular Drugs Growth	-0.88%
Antineoplastic Drugs	973.34M
Antineoplastic Drugs Growth	14.34%
Imported Pharmaceutical Preparations and Outsourced Pharmaceutical Marketing	822.40M
Imported Pharmaceutical Preparations and Outsourced Pharmaceutical Marketing Growth	28.15%
Anti-parasitic and Veterinary Drugs	713.45M
Anti-parasitic and Veterinary Drugs Growth	-14.07%
Other Drugs	621.98M
Other Drugs Growth	8.62%
Endocrine Drugs	510.33M
Endocrine Drugs Growth	48.59%
Other Business	215.22M
Other Business Growth	-0.14%
Other	16.90M
Other Growth	-50.93%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
China	8.98B
China Growth	-4.47%
Foreign	594.27M
Foreign Growth	-21.84%